Research on safety strategies for nucleic acid testing in sudden epidemic conditions based on a SEIARD dynamic model
- PMID: 39271691
- PMCID: PMC11399412
- DOI: 10.1038/s41598-024-71595-w
Research on safety strategies for nucleic acid testing in sudden epidemic conditions based on a SEIARD dynamic model
Abstract
Infectious diseases have caused enormous disasters in human society, and asymptomatic carriers are an important challenge in our epidemic prevention and control process. Nucleic acid testing has played an important role in rapid testing for asymptomatic individuals. How to carry out nucleic acid testing in a scientific manner is a practical problem encountered in normal production and life. Based on the real COVID-19 epidemic data from Shanghai, we established a susceptible-exposed-infected-asymptomatic-recovered-death (SEIARD) dynamic model. The least squares method was used to fit the data and estimate the unknown parameters β and E(0) in the model, and MATLAB software was employed to simulate the development of the epidemic. The data fitting results indicated that the SEIARD model can better describe the early development patterns of the epidemic (R2 = 0.98; MAPE = 2.54%). We calculated the basic reproduction number of the Shanghai epidemic as R0 = 2.86. As the frequency of nucleic acid testing increased, the basic reproduction number R0 continued to decrease. When there is one latent carrier and one asymptomatic carrier in the nucleic acid testing team, the number of queues is directly proportional to the number of infected individuals, the nucleic acid testing team increases by 50 people, and the number of new asymptomatic cases increases by approximately 4 people. If both susceptible individuals (S) and asymptomatic patients (A) are not wearing masks, the infection rate reaches approximately 7%; after wearing masks, the final infection rate is less than 1% at 1.5 m between two people. The queue spacing is inversely proportional to the number of infected individuals. With a distance of d = 1 m, a nucleic acid testing team of 100 people added 8% of the infected individuals; when d = 1.5 m, fewer than 2% of the newly infected individuals. The results confirmed that controlling the queue size for nucleic acid testing, strictly wearing masks, and maintaining a queue spacing of more than 1.5 m are safe and effective nucleic acid testing strategies. Our findings are also applicable to the prevention of other newly emerging infectious diseases.
Keywords: Infectious diseases; Nucleic acid testing; SEIARD model; Simulation.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z. Trials. 2021. PMID: 33419461 Free PMC article.
-
A network-based model to explore the role of testing in the epidemiological control of the COVID-19 pandemic.BMC Infect Dis. 2021 Jan 12;21(1):58. doi: 10.1186/s12879-020-05750-9. BMC Infect Dis. 2021. PMID: 33435892 Free PMC article.
-
Tracing day-zero and forecasting the COVID-19 outbreak in Lombardy, Italy: A compartmental modelling and numerical optimization approach.PLoS One. 2020 Oct 30;15(10):e0240649. doi: 10.1371/journal.pone.0240649. eCollection 2020. PLoS One. 2020. PMID: 33125393 Free PMC article.
-
Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses.Curr Med Res Opin. 2021 Feb;37(2):207-217. doi: 10.1080/03007995.2020.1862532. Epub 2020 Dec 26. Curr Med Res Opin. 2021. PMID: 33306409 Free PMC article. Review.
-
Physical interventions to interrupt or reduce the spread of respiratory viruses.Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6. Cochrane Database Syst Rev. 2023. PMID: 36715243 Free PMC article. Review.
References
-
- World Health Organization. SARS Outbreak: WHO Investigation Team Moves to Guangdong China (World Health Organization, 2003).
-
- None. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N. Engl. J. Med. 361(20):1925–1934 (2009). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
